Content
Introduction
History
Classification & Clinical Features
Epidemiology
Localized Aggressive Periodontitis
Generalized Aggressive Periodontitis
Histopathology
Etiology and Pathogenesis
Diagnosis and Treatment
Conclusion
References
Introduction
Group of rare, often severe, rapidly progressive forms of
periodontitis often characterized by an early age of clinical
manifestation and a distinctive tendency for cases to
aggregate in families
History
Terminology Investigator Year
Diffuse atrophy of alveolar bone Gottlieb 1923
Deep cementopathia Gottlieb 1928
Paradontitis marginalis progressiva Wannenmacher 1938
Paradontosis Thoma & Goldman 1940
Periodontosis Orban & Weinmann 1942
Acute juvenile periodontitis Chaput 1967
Juvenile periodontitis Butler 1969
History
Localized generalized periodontosis Baer 1971
Periodontitis complex Box 1972
Localized periodontosis Fourel 1972
Gottlieb syndrome Fourel 1974
Destructive juvenile periodontitis Waerhaug 1977
Periodontosis Baer & Kaslick 1978
Juvenile periodontitis Page & Schroeder 1982
“A disease of the periodontium occurring in an otherwise healthy
adolescent which is characterized by a rapid loss of alveolar bone
about more than one tooth of the permanent dentition. The amount
of destruction manifested is not commensurate with the amount of
local irritants.”
Baer 1971
History
Early Onset Periodontitis
Prepubertal periodontitis
Juvenile periodontitis
Rapidly progressive periodontitis
Caton, 1989 World Workshop in Clinical Periodontics
Aggressive Periodontitis
Lang , 1999 International Workshop for
Classification of Periodontal Diseases
Classification & Clinical features
Primary features
Clinically healthy
Rapid attachment loss
& bone destruction
Familial aggregation
Secondary features
Inconsistent amounts of microbial
deposits
Elevated proportions of A.a, P.g
Phagocyte abnormalities
Hyper-responsive macrophage
phenotype
Progression of attachment & bone
loss may be self-arresting
Lang et al, 1999
Classification & Clinical features
Localized Aggressive Periodontitis (LAP)
Generalized Aggressive Periodontitis (GAP)
Lang et al. 1999; Tonetti & Mombelli 1999
Epidemiology
Rapid progression : 8%
Loe 1986
Adolescents (14 - 17yrs) : 0.13%
Loe 1991
LAP : < 1% (0.2% - 2.6%)
Loe & Brown 1991
Black males > Black females >White females > White males
Melvin 1991
Individuals < 35 years : 1% - 15%
Demmer & Papapanou 2010
Epidemiology
Madras : 0.01% Miglani et al. 1965
Bombay : 6.80% Rao et al. 1968
17.60% Day et al. 1949
Localized Aggressive Periodontitis
Localized distribution of lesions
Adequate immune defenses after initial colonization
Zambon 1983
Bacteria antagonistic to A.a may colonize periodontal tissues
Hillman 1982
A.a might lose its leukotoxin producing ability
Slots 1982
Defect in cementum formation
Page 1985
Localized Aggressive Periodontitis
Lack of clinical inflammation
Deep periodontal pockets
Gingival index, gingival bleeding & suppuration scores
Burmeister et al. 1984
Minimal amount of plaque
Elevated levels of A.a & P.g
Rate of bone loss : 3 - 4 times faster
Baer 1971
Generalized Aggressive Periodontitis
Attachment loss ≥ 8 teeth, at least 3 of which were not 1st molars
or incisors
Burmeister et al. 1984
Generalized interproximal attachment loss affecting at least 3
permanent teeth other than first molars & incisors
Lang, AAP Consensus Report,1999
Plaque : Inconsistent
P.g, A.a, T.f
Etiology & Pathogenesis
A.a is the key microorganism in LAP
> 90% of LAP sites (Slots et al, 1990)
Disease progression show elevated levels of A.a (ie ongoing
sites – haffajee et al, 1994)
Virulence factors (like leukotoxin) – Zambon, 1988
Elevated serum antibody titers to A.a ( Listgarten, 1981)
Reduction in subgingival load of A.a during treatment
(Haffajee et al, 1994)
Socransky & Haffajee 1992, Tonetti & Mombelli1999
Etiology & Pathogenesis
Viral etiology
EBV & CMV
LAP : Odds ratio
Michalowicz 2000
Cytomegalovirus : 6.6 P. gingivalis : 8.7
Cytomegalovirus + P. gingivalis : 51.4
Etiology & Pathogenesis
Herpesvirus like virions found signifying active viral infection.
Burghelea,1990
Primary CMV infection at time of root formation : Defective
periodontium
Ting et al. 2000
CMV infection early in life : Cemental hypoplasia
Reactivation during hormonal changes during puberty:
Suppression of antibacterial immune defenses, increaing chancesof
infection
Slots 2010
Etiology & Pathogenesis
Active CMV infection were heavily infected with A.a as compared
to latent infection.
73% - 78% GAP : HSV1, EBV & CMV
Saygun 2004
Etiology & Pathogenesis
Herpesvirus infection : Pathogenicity of periodontal microbiota
Direct cytopathic effects
CMV : Enhance adherence of A.a
Induce abnormalities in PMNs
EBV : Neutropenia & stimulate proliferation of B-lymphocytes
Up-regulate the IL-1β & TNF-α gene expression of monocytes &
macrophages
Slots 2010
Etiology & Pathogenesis
Immunological factors
Intense recruitment of PMNs : Tissues & Pocket
B cells & plasma cells : Connective tissue lesion
Liljenberg & Lindhe 1980
Plasma cells : IgG-producing cells
Local inflammatory infiltrate : T cells
Depressed T-helper to T suppressor ratio
PGE2, IL-1α, IL-1β
Masada et al. 1990, Offenbacher et al. 1993
Etiology & Pathogenesis
Impaired Neutrophil Model in Aggressive Periodontitis
Reduced chemotaxis to f- Met- Leu- Phe (72% - 86%)
Lavine 1979, Page 1984,1985, Altman 1985
Reduced chemotaxis without f- Met- Leu- Phe stimulation
Page 1993
Reduction in number
of receptors
Defect in f-Met-Leu-Phe receptor or
co-receptors (GP110 or CD38)
Etiology & Pathogenesis
Impaired phagocytosis & killing
LAP (53%) & GAP (46%) : % of PMNs with phagocytosed
particles & numbers of phagocytosed particles per PMN
Kimura et al 1992
GCF : LL-37 cathelicidin & peptide 1-3 defensin
Puklo et al 2008
Polymorphisms in Fcγ receptor : Phagocytosis of
periodontopathic bacteria
Kaneko 2004, Nibali 2006
Etiology & Pathogenesis
Concept of a Hyperactive or Primed Neutrophil
Hyperactive ⁄ primed neutrophil : Tissue destruction
Kantarci et al 2005
Increased intracellular levels of beta-glucuronidase
Pippin 2000
Baseline levels of myeloperoxidase : Correlated with bleeding &
suppurating sites
Kaner 2006
Etiology & Pathogenesis
Genetic factors
Familial Aggregation
US survey (1996) of 7447 dentate individuals : 40% - 50%
siblings in families similarly affected
Segregation Analyses
Dominant + Recessive
Autosomal dominant : Largest study in U.S. in African-American
& Caucasian families
Marazita et al 1994
Etiology & Pathogenesis
Linkage Analysis
Vitamin D binding locus on 4q in a large family of Brandywine
population Boughman et al. 1986
q25 region of chromosome 1 in an area close to COX-2 gene
Li et al. 2004
Chromosome 2q13–14 that contains the IL-1 gene complex
Scapoli et al. 2005
Etiology & Pathogenesis
Gene polymorphisms
IL-1B +3954
Quappe 2004, Scapolli 2005
No IL gene polymorphisms : Aggressive periodontitis
Prakash et al 2010, Shete et al 2010
Vitamin D Receptor RFLP Fok1 : Risk of developing GAP
Li et al 2008
Etiology & Pathogenesis
Fc γ receptor IIIB NA1/NA1 genotype : Chinese population
Fu 1999, Zhang 2003
Fc γ receptor IIA R131 allele : Taiwanese population
Chung 2003
HLA-A9 & -B15 : Aggressive periodontitis
HLA-A2 & -B5 : Potential protective factors
Shapira et al 1994
Etiology & Pathogenesis
Environmental factors
Cigarette smoking : Risk factor for GAP
More affected teeth and greater mean levels of attachment loss
Schenkein et al. 1995
GAP group : Significantly increased depression & loneliness
Monteiro da Silva 1996
Etiology & Pathogenesis
Microbial exposure & infection
A. a
Environmental modifying factors
Cigarette smoking
P.g & other bacteria
Genetic predisposition
Autosomal dominance inheritance
Genetic modifying factors
IgG2 response against A. a
Immunoglobulin response against other
bacteria
Normal LAP GAP
Environmental Factors
Genetic Factors
Diagnosis and Treatment
15-year follow-up study
LAP : Stabilize over time
GAP : Increasing amounts of attachment & tooth loss
LAP : Gain in periodontal attachment with SRP & surgery
Gunsolley et al. 1995
Diagnosis and Treatment
LAP
Mechanical debridement + chemotherapeutic agents
Predominant culturable microbiota susceptible to tetracycline
A.a penetrated pocket epithelium
Root surface debridement + tetracycline : Successful in treating
most LAP sites
Slots & Rosling 1986
Diagnosis and Treatment
Rationale for surgery
Modified Widman flap surgery + tetracycline regimen
Lindhe & Liljenberg 1984, Kornman & Robertson 1985
Regenerative techniques
Autogenous grafts
Freeze-dried bone allograft : Average defect fill 80%
Yukna & Sepe 1982
GTR Sirirat et al 1996
Diagnosis and Treatment
GAP
SRP : 1 mm reduction in probing depth and a 0.5 mm gain in
attachment levels
Purucker et al 2001
Nonsurgical root surface debridement : Mean reduction in probing
depth of 2.11 mm & mean attachment level gain of 1.77 mm
Hughes et al. 2006
Diagnosis and Treatment
SRP + Metronidazole & amoxicillin : Sites > 7 mm, additional 1.4
mm reduction in PD & 1 mm gain in attachment level
Disease progression at 6 months : 1.5% of sites in patients of
antibiotic group & 3.3% of sites in controls
Guerrero et al. 2007
Metronidazole & clindamycin significantly improved the clinical
response
Sigusch et al. 2001
Diagnosis and Treatment
Metronidazole ⁄ amoxicillin 6 weeks after SRP : PD > 6 mm
significantly reduced
Xajigeorgiou et al. 2006
Immediately after SRP
Kaner et al. 2007
Tetracycline fibers + SRP > SRP
Sakellari 2003
Diagnosis and Treatment
SRP + Systemic antibiotics (24 h before SRP)
Re-evaluation at 4- 6 weeks
Resolution of disease indicators No significant positive response
Maintenance / Surgical phase Initial phase
Culture & sensitivity
Subgingival scaling + Different antibiotic regimen
Deas & Mealey 2010
Diagnosis and Treatment
Surgical modalities
Maintenance program – call pt every1month for 6 motnhs, then
call every 2 months for 6 months following which call every 3
months
Isolated sites of recurring disease – SRP of that site n tetracycline
fibers
Generalized recurrence- full mouth SRP + systemic antibiotics.
Diagnosis and Treatment
Implants
Survival rate : 56% -100%
Malmstrom et al 1990, Mengel et al 2005
>90%
Impaired host response
Lower implant survival rates
After controlling dental & periodontal diseases
Al-Zahrani 2008
Conclusion
Thorough understanding of the etiopathogenesis and clinical
features of aggressive periodontitis and the therapeutic
approaches available is essential to provide the patient with the
best chances of successful treatment outcomes
References
Newman MG, Takei HH, Klokevold PR, Carranza FA. Carranza’s
Clinical Periodontology. Saunders Elsevier;10th Edition.
Lindhe, Karring, Lang. Clinical Periodontology & Implant Dentistry.
Blackwell Munksgaard; 5th Edititon.
Armitage GC, Cullinan MP, SeymourGJ. Comparative biology of
chronic and aggressive periodontitis: introduction. Periodontol 2000
2010;53.
L A Wisner-Lynch, W V Giannobile. Current concepts in juvenile
periodontitis. Current opinion in Periodontology 1993: 28-42.
References
Lang N, Bartold PM, Cullinas M et al. Consensus report: Aggressive
periodontitis . Ann Peridontol 1999; 4: 32-37.
Meng H, Xu L, Li Q, Han J, Zhao Y. Determinants of host
susceptibility in aggressive periodontitis. Periodontol 2000
2007;43:133-59.
Ryder MI. Comparison of neutrophil functions in aggressive and
chronic periodontitis. Periodontol 2000 2010;53: 124-137.
Al-Zahrani MS. Implant therapy in aggressive periodontitis patients:
a systematic review and clinical implications. Quintessence Int. 2008
Mar;39(3):211-215.
Editor's Notes
Periodontosis with periodontitis
Kaslick & Chasens
1968
Localized juvenile periodontitis
Hormond
1979
Prevalence of aggressive periodontitis among individuals younger than 35 years of age ranges from approximately 1% to a maximum of 15%, depending on the age of participants and the study
Demmer & Papapanou
Prevalence of aggressive periodontitis among individuals younger than 35 years of age ranges from approximately 1% to a maximum of 15%, depending on the age of participants and the study
Demmer & Papapanou
Streptococcus sanguis and aa- h2o2 production by ss & amplification of host response can kill bacteria
Perhaps the most characteristic event in neutrophil priming or hyperactivity is an increase in the synthesis and release of oxidative burst products, such as superoxide, hydroxyl radicals and hydrogen peroxide, from both resting and stimulated cells.
Mombelli et al 2002, the presence or absence of A.a or P.g could not discriminate between subjects with AgP from those of chronic periodontitis. But it is ten times more likely that an A.a negative subject suffers from chronic than aggressive periodontitis
metronidazole 500 mg three times daily plus amoxicillin 500 mg three times daily is probably the most popular antibiotic regimen in the current literature